Study of the tissue distribution of potential boron neutron-capture therapy agents based on conjugates of chlorin e6 aminoamide derivatives with boron nanoparticles


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Boron neutron-capture therapy of cancer is based on the ability of the 10B isotope to capture thermal neutrons; it is one of the most promising techniques in radiation therapy. The high content and selective accumulation of 10B in the tumor tissue are the most important prerequisites for its efficacy. The purpose of this study was to determine the biodistribution of cobalt bis(dicarbollide) conjugates with chlorin e6 amino amide derivatives. Experiments were carried out in Balb/c mice with transplanted CT-26 murine colon carcinoma. Boron-containing conjugates were injected into the tail vein at a dose of 10 mg/kg. The conjugate accumulation in tumor tissue and organs was studied by laser scanning microscopy. Excitation was performed at the wavelength of 514 nm; the signals were recorded in the range of 560–710 nm in increments of 10 nm. To evaluate the amount of the boron conjugate, we calculated the intensity of the fluorescence signal of the samples under investigation. At 3 h after administration of the agent, a high level of fluorescence was observed in the liver, spleen, and lung. The tumor/muscle accumulation ratio was approximately 3. The study demonstrated that boron derivatives of chlorin e6 are promising agents for boron neutron-capture therapy.

About the authors

A. B. Volovetskiy

Lobachevsky State University of Nizhny Novgorod

Author for correspondence.
Email: voloveckiy91@gmail.com
Russian Federation, pr. Gagarina 23, Nizhny Novgorod, 603950

N. Y. Shilyagina

Lobachevsky State University of Nizhny Novgorod

Email: voloveckiy91@gmail.com
Russian Federation, pr. Gagarina 23, Nizhny Novgorod, 603950

V. V. Dudenkova

Lobachevsky State University of Nizhny Novgorod

Email: voloveckiy91@gmail.com
Russian Federation, pr. Gagarina 23, Nizhny Novgorod, 603950

S. O. Pasynkova

Moscow State University of Fine Chemical Technologies

Email: voloveckiy91@gmail.com
Russian Federation, pr. Vernadskogo 86, Moscow, 119571

A. A. Ignatova

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry; Moscow State University

Email: voloveckiy91@gmail.com
Russian Federation, ul. Mikluho-Maklaya 16/10, Moscow, 117997; Moscow, 119234

A. F. Mironov

Moscow State University of Fine Chemical Technologies

Email: voloveckiy91@gmail.com
Russian Federation, pr. Vernadskogo 86, Moscow, 119571

M. A. Grin

Moscow State University of Fine Chemical Technologies

Email: voloveckiy91@gmail.com
Russian Federation, pr. Vernadskogo 86, Moscow, 119571

V. I. Bregadze

Nesmeyanov Institute of Organoelement Compounds

Email: voloveckiy91@gmail.com
Russian Federation, ul. Vavilova 28, Moscow, 119991

A. V. Feofanov

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry; Moscow State University

Email: voloveckiy91@gmail.com
Russian Federation, ul. Mikluho-Maklaya 16/10, Moscow, 117997; Moscow, 119234

I. V. Balalaeva

Lobachevsky State University of Nizhny Novgorod

Email: voloveckiy91@gmail.com
Russian Federation, pr. Gagarina 23, Nizhny Novgorod, 603950

A. V. Maslennikova

Lobachevsky State University of Nizhny Novgorod; Nizhny Novgorod State Medical Academy

Email: voloveckiy91@gmail.com
Russian Federation, pr. Gagarina 23, Nizhny Novgorod, 603950; pl. Minina i Pozharskogo 10/1, Nizhny Novgorod, 603005

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Inc.